Preface
The promise of emerging developments and concepts in mesothelioma
Translational Lung Cancer Research
2017;
6
(3)
:246-247
.
(29 June 2017)
Review Article
In vitro experimental models of mesothelioma revisited
Translational Lung Cancer Research
2017;
6
(3)
:248-258
.
(29 June 2017)
Diagnostic and prognostic biomarkers for malignant mesothelioma: an update
Translational Lung Cancer Research
2017;
6
(3)
:259-269
.
(29 June 2017)
BAP1, a tumor suppressor gene driving malignant mesothelioma
Translational Lung Cancer Research
2017;
6
(3)
:270-278
.
(29 June 2017)
Intraoperative near-infrared imaging of mesothelioma
Translational Lung Cancer Research
2017;
6
(3)
:279-284
.
(29 June 2017)
Intraoperative adjuncts for malignant pleural mesothelioma
Translational Lung Cancer Research
2017;
6
(3)
:285-294
.
(29 June 2017)
Novel systemic therapy against malignant pleural mesothelioma
Translational Lung Cancer Research
2017;
6
(3)
:295-314
.
(29 June 2017)
Immunotherapy for malignant pleural mesothelioma: current status and future directions
Translational Lung Cancer Research
2017;
6
(3)
:315-324
.
(29 June 2017)
Radio-immunotherapy and chemo-immunotherapy as a novel treatment paradigm in malignant pleural mesothelioma
Translational Lung Cancer Research
2017;
6
(3)
:325-334
.
(29 June 2017)
Drug development against the hippo pathway in mesothelioma
Translational Lung Cancer Research
2017;
6
(3)
:335-342
.
(29 June 2017)
Targeting eukaryotic protein translation in mesothelioma
Translational Lung Cancer Research
2017;
6
(3)
:343-349
.
(29 June 2017)
Targeting the epigenome in malignant pleural mesothelioma
Translational Lung Cancer Research
2017;
6
(3)
:350-365
.
(29 June 2017)
Original Article
The use of TCP based EUD to rank and compare lung radiotherapy plans: in-silico study to evaluate the correlation between TCP with physical quality indices
Translational Lung Cancer Research
2017;
6
(3)
:366-372
.
(29 June 2017)
Review Article
Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic Oncology
Translational Lung Cancer Research
2017;
6
(3)
:373-386
.
(29 June 2017)
Case Report
Do we really care about incidental lung nodules?—Review of atypical lung carcinoid and a proposal for systematic patient follow up
Translational Lung Cancer Research
2017;
6
(3)
:387-392
.
(29 June 2017)
Editorial
Combination MET- and EGFR-directed therapy in MET-overexpressing non-small cell lung cancers: time to move on to better biomarkers?
Translational Lung Cancer Research
2017;
6
(3)
:393-395
.
(29 June 2017)
Disclosure:
The focused issue “Malignant Pleural Mesothelioma: Updates and New Directions” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Chuong D. Hoang served as the unpaid Guest Editor for the focused issue.
